Low-risk myelodysplastic syndromes
Clinical trials for Low-risk myelodysplastic syndromes explained in plain language.
Never miss a new study
Get alerted when new Low-risk myelodysplastic syndromes trials appear
Sign up with your email to follow new studies for Low-risk myelodysplastic syndromes, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Could a Centuries-Old poison become a new weapon against a blood disorder?
Disease control Recruiting nowThis early-stage trial is testing whether an oral form of arsenic trioxide can safely help people with low-risk myelodysplastic syndromes (MDS) who have not improved with standard treatments. The study will first find the safest dose, then check how well it works after several cy…
Matched conditions: LOW-RISK MYELODYSPLASTIC SYNDROMES
Phase 1 • Sponsor: Groupe Francophone des Myelodysplasies • Aim: Disease control
Last updated Sep 12, 2026 00:00 UTC
-
New drug R289 offers hope for blood disorder patients who failed other therapies
Disease control Recruiting nowThis study tests an experimental drug called R289 in about 86 adults with a type of blood cancer called lower-risk myelodysplastic syndromes (MDS). Participants must have tried other standard treatments without success. The main goal is to check the drug's safety and side effects…
Matched conditions: LOW-RISK MYELODYSPLASTIC SYNDROMES
Phase 1/2 • Sponsor: Rigel Pharmaceuticals • Aim: Disease control
Last updated Aug 12, 2026 00:00 UTC